Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANDKLINIKKEN PERLEGADE 13 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   9.0% 7.9% 5.3% 3.3% 5.2% 3.3% 10.4% 10.4%   Credit score (0-100)   29 32 42 53 42 54 24 24   Credit rating   BB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,517 2,377 2,497 2,343 2,016 2,487 0.0 0.0   EBITDA   292 279 335 1,125 429 788 0.0 0.0   EBIT   -7.0 11.7 44.8 828 170 529 0.0 0.0   Pre-tax profit (PTP)   -128.6 -121.7 -115.9 680.9 23.7 408.8 0.0 0.0   Net earnings   -100.6 -95.0 -90.4 531.1 16.8 318.8 0.0 0.0   Pre-tax profit without non-rec. items   -129 -122 -116 681 23.7 409 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   683 491 847 868 749 565 0.0 0.0   Shareholders equity total   94.9 -0.1 -90.5 441 343 544 419 419   Interest-bearing liabilities   0.0 0.0 1,643 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,111 2,129 2,419 2,259 2,058 2,333 419 419   Net Debt   -312 -620 1,215 -295 -435 -924 -44.0 -44.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,517 2,377 2,497 2,343 2,016 2,487 0.0 0.0   Gross profit growth   -5.5% -5.6% 5.1% -6.2% -13.9% 23.4% -100.0% 0.0%   Employees   4 4 4 4 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,111 2,129 2,419 2,259 2,058 2,333 419 419   Balance sheet change%   -13.3% 0.9% 13.7% -6.6% -8.9% 13.4% -82.0% 0.0%   Added value   292.2 279.4 334.8 1,124.6 466.7 788.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -682 -535 -9 -351 -453 -519 -565 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -0.3% 0.5% 1.8% 35.3% 8.4% 21.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.5% 1.5% 2.3% 35.2% 8.3% 24.4% 0.0% 0.0%   ROI %   3.5% 17.8% 5.9% 74.4% 38.4% 107.8% 0.0% 0.0%   ROE %   -50.8% -8.5% -4.0% 37.1% 4.3% 71.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   4.5% -0.0% -3.6% 19.5% 16.7% 23.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -106.7% -222.0% 362.9% -26.2% -101.3% -117.2% 0.0% 0.0%   Gearing %   0.0% 0.0% -1,815.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 20.7% 19.4% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.4 0.4 0.4 0.5 0.7 0.0 0.0   Current Ratio   0.4 0.5 0.4 0.5 0.5 0.8 0.0 0.0   Cash and cash equivalent   311.7 620.2 427.3 294.9 434.5 924.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,210.7 -1,066.7 -1,463.6 -886.5 -807.7 -374.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   73 70 84 281 117 197 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   73 70 84 281 107 197 0 0   EBIT / employee   -2 3 11 207 42 132 0 0   Net earnings / employee   -25 -24 -23 133 4 80 0 0